Sino Biopharmaceutical (OTCMKTS:SBMFF) Sees Significant Increase in Short Interest

Sino Biopharmaceutical (OTCMKTS:SBMFF) was the target of a large increase in short interest in March. As of March 13th, there was short interest totaling 98,069,575 shares, an increase of 35.7% from the February 26th total of 72,283,620 shares. Based on an average trading volume of 462 shares, the short-interest ratio is currently 212,271.8 days. Approximately 0.5% of the company’s stock are sold short.

Sino Biopharmaceutical Price Performance

SBMFF opened at $0.76 on Monday. Sino Biopharmaceutical has a 1 year low of $0.45 and a 1 year high of $1.24. The company has a quick ratio of 1.28, a current ratio of 1.36 and a debt-to-equity ratio of 0.07. The firm’s fifty day moving average price is $0.84 and its two-hundred day moving average price is $0.90.

About Sino Biopharmaceutical

Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.

The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.